|
| | Publication Year | Title | Author(s) |
| 1 | Apr-2020 | Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma. | Cebon, Jonathan S ; Gore, Martin; Thompson, John F; Davis, Ian D; McArthur, Grant A; Walpole, Euan; Smithers, Mark; Cerundolo, Vincenzo; Dunbar, P Rod; MacGregor, Duncan; Fisher, Cyril; Millward, Michael; Nathan, Paul; Findlay, Michael P N; Hersey, Peter; Evans, T R Jeffry; Ottensmeier, Christian Hermann; Marsden, Jeremy; Dalgleish, Angus G; Corrie, Pippa G; Maria, Marples; Brimble, Margaret; Williams, Geoff; Winkler, Sintia; Jackson, Heather M; Endo-Munoz, Liliana; Tutuka, Candani S A; Venhaus, Ralph; Old, Lloyd J; Haack, Dennis; Maraskovsky, Eugene; Behren, Andreas; Chen, Weisan |
| 2 | Mar-2017 | A pilot study of peripheral blood BDCA-1 (CD1c) positive dendritic cells pulsed with NY-ESO-1 ISCOMATRIX™ adjuvant | Davis, Ian D; Quirk, Juliet; Morris, Leone; Seddon, Lauren; Tai, Tsin Yee; Whitty, Genevieve; Cavicchiolo, Tina; Ebert, Lisa; Jackson, Heather; Browning, Judy; MacGregor, Duncan; Wittke, Frederick; Winkels, Gregor; Alex, Regina; Miloradovic, Lena; Maraskovsky, Eugene; Chen, Weisan; Cebon, Jonathan S |
| 3 | Feb-2016 | Mycoplasma Infection Alters Cancer Stem Cell Properties in Vitro. | Gedye, Craig; Cardwell, Tracy; Dimopoulos, Nektaria; Tan, Bee Shin; Jackson, Heather M; Svobodová, Suzanne; Anaka, Matthew; Behren, Andreas; Maher, Christopher; Hofmann, Oliver; Hide, Winston; Caballero, Otavia; Davis, Ian D; Cebon, Jonathan S |
| 4 | 7-Feb-2015 | Low-dose cyclophosphamide enhances antigen-specific CD4(+) T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanoma. | Klein, Oliver ; Davis, Ian D; McArthur, Grant A; Chen, Li; Haydon, Andrew; Parente, Phillip; Dimopoulos, Nektaria; Jackson, Heather M; Xiao, Kun; Maraskovsky, Eugene; Hopkins, Wendie; Stan, Rodica; Chen, Weisan; Cebon, Jonathan S |
| 5 | 1-Apr-2014 | A single-centre experience of patients with metastatic melanoma enrolled in a dabrafenib named patient programme. | Lau, David K ; Andrews, Miles C; Turner, Natalie; Azad, Arun A; Davis, Ian D; Cebon, Jonathan S |
| 6 | 11-Oct-2013 | Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors. | Anaka, Matthew; Hudson, Christopher; Lo, Pu-Han; Do, Hongdo; Caballero, Otavia L; Davis, Ian D; Dobrovic, Alexander ; Cebon, Jonathan S ; Behren, Andreas |
| 7 | 11-Apr-2013 | The Ludwig institute for cancer research Melbourne melanoma cell line panel. | Behren, Andreas; Anaka, Matthew; Lo, Pu-Han; Vella, Laura J; Davis, Ian D; Catimel, Jenny; Cardwell, Tracy; Gedye, Craig; Hudson, Christopher; Stan, Rodica; Cebon, Jonathan S |
| 8 | 26-Oct-2012 | A cancer vaccine induces expansion of NY-ESO-1-specific regulatory T cells in patients with advanced melanoma. | Ebert, Lisa M; MacRaild, Sarah E; Zanker, Damien; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan |
| 9 | 6-Sep-2012 | A novel HLA-B18 restricted CD8+ T cell epitope is efficiently cross-presented by dendritic cells from soluble tumor antigen. | Zhao, Rona Y; Mifsud, Nicole A; Xiao, Kun; Chan, Kok-Fei; Oveissi, Sara; Jackson, Heather M; Dimopoulos, Nektaria; Guillaume, Philippe; Knights, Ashley J; Lowen, Tamara; Robson, Neil C; Russell, Sarah E; Scotet, Emmanuel; Davis, Ian D; Maraskovsky, Eugene; Cebon, Jonathan S ; Luescher, Immanuel F; Chen, Weisan |
| 10 | 1-Feb-2012 | Stem cell media culture of melanoma results in the induction of a nonrepresentative neural expression profile. | Anaka, Matthew; Freyer, Claudia; Gedye, Craig; Caballero, Otavia; Davis, Ian D; Behren, Andreas; Cebon, Jonathan S |
| 11 | 13-Jan-2012 | A novel method for detecting antigen-specific human regulatory T cells. | Ebert, Lisa M; MacRaild, Sarah E; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan |
| 12 | 23-Jun-2011 | Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™. | Nicholaou, Theo; Chen, Weisan; Davis, Ian D; Jackson, Heather M; Dimopoulos, Nektaria; Barrow, Catherine; Browning, Judy; Macgregor, Duncan; Williams, David; Hopkins, Wendie; Maraskovsky, Eugene; Venhaus, Ralph; Pan, Linda; Hoffman, Eric W; Old, Lloyd J; Cebon, Jonathan S |
| 13 | 1-Jun-2011 | Melanoma vaccines: developments over the past 10 years. | Klein, Oliver ; Schmidt, Christopher; Knights, Ashley J; Davis, Ian D; Chen, Weisan; Cebon, Jonathan S |
| 14 | 4-Nov-2010 | Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate. | Svobodová, Suzanne; Browning, Judy; MacGregor, Duncan; Pollara, Gabriele; Scolyer, Richard A; Murali, Rajmohan; Thompson, John F; Deb, Siddhartha; Azad, Arun A; Davis, Ian D; Cebon, Jonathan S |
| 15 | 7-Nov-2009 | Cancer stem cells in urologic cancers. | Gedye, Craig; Davidson, Adee-Jonathan; Elmes, Martin R; Cebon, Jonathan S ; Bolton, Damien M ; Davis, Ian D |
| 16 | 10-Mar-2009 | Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trial. | Davis, Ian D; Brady, Ben; Kefford, Richard F; Millward, Michael; Cebon, Jonathan S ; Skrumsager, Birte K; Mouritzen, Ulrik; Hansen, Lasse Tengbjerg; Skak, Kresten; Lundsgaard, Dorthe; Frederiksen, Klaus Stensgaard; Kristjansen, Paul E G; McArthur, Grant A |
| 17 | 10-Mar-2009 | Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma. | Nicholaou, Theo; Ebert, Lisa M; Davis, Ian D; McArthur, Grant A; Jackson, Heather M; Dimopoulos, Nektaria; Tan, Bee; Maraskovsky, Eugene; Miloradovic, Lena; Hopkins, Wendie; Pan, Linda; Venhaus, Ralph; Hoffman, Eric W; Chen, Weisan; Cebon, Jonathan S |
| 18 | 17-Feb-2009 | Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells. | Gedye, Craig; Quirk, Juliet; Browning, Judy; Svobodová, Suzanne; John, Thomas ; Sluka, Pavel; Dunbar, P Rod; Corbeil, Denis; Cebon, Jonathan S ; Davis, Ian D |
| 19 | 27-Jan-2009 | A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design. | Ebert, Lisa M; Liu, Yu Chih; Clements, Craig S; Robson, Neil C; Jackson, Heather M; Markby, Jessica L; Dimopoulos, Nektaria; Tan, Bee Shin; Luescher, Immanuel F; Davis, Ian D; Rossjohn, Jamie; Cebon, Jonathan S ; Purcell, Anthony W; Chen, Weisan |
| 20 | 15-Aug-2008 | Predicting clinical outcome through molecular profiling in stage III melanoma. | John, Thomas ; Black, Michael A; Toro, Tumi T; Leader, Debbie; Gedye, Craig A; Davis, Ian D; Guilford, Parry J; Cebon, Jonathan S |
Loading...
2
0
20
0
false
0000-0002-3898-950x